Barclays »

Plus Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $1 2 0.50
2025-06-30 $0 102 0.00
2025-03-31 $1.0k 1.0k 0.96

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Plus Therapeutics

Vanguard Group
UBS Group
Geode Capital Management
BlackRock
State Street Corporation
Northern Trust
Scientech Research
Susquehanna International
Mercer Global Advisors
Dagco
Kestra Advisory Services
Ashton Thomas Private Wealth
Cambridge Investment Research Advisors
Cubist Systematic Strategies
Two Sigma Securities

View all funds holding Plus Therapeutics